Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-011377

Options or other derivatives

  • Chief Medical Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bahrt Kenneth · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-19 Grant or award : show line 1 in the form Stock Option (Right to Buy) +600,000 600,000 D
Loading xslF345X03/doc4.xml…